Table-II.
The correlation of HPV16/18 DNA, p53 protein and breast cancer
| Classification | n |
HPV16/18 DNA
|
p53 protein
|
|||
|---|---|---|---|---|---|---|
| Positive (%) | Positive (%) | |||||
| Age | ||||||
| < 50 | 16 | 7(43. 8) | 6(37. 5) | |||
| ≥50 | 29 | 16(55. 2) | 15(51. 7) | |||
| X2 | 0. 538 | 0. 838 | ||||
| P | 0. 463 | 0. 360 | ||||
| Tumor Size | ||||||
| <2cm | 18 | 8(44. 4) | 7(38. 9) | |||
| ≥2cm | 27 | 15(55. 6) | 14(51. 9) | |||
| X2 | 0. 534 | 0. 729 | ||||
| P | 0. 465 | 0. 393 | ||||
| TMN Stage | ||||||
| Stage I | 11 | 4(45. 5) | 3(27. 3) | |||
| Stage II | 25 | 13(48. 0) | 10(40. 0) | |||
| Stage III | 9 | 6(66. 7) | 8(88. 9) | |||
| X2 | 1. 128 | 8. 555 | ||||
| P | 0. 569 | 0. 014 | ||||
| Lymph Nodes Metastasis | ||||||
| No | 16 | 5(31. 3) | 4(25. 0) | |||
| Yes | 29 | 18(62. 1) | 17(58. 6) | |||
| X2 | 3. 919 | 0. 683 | ||||
| P | 0. 048 | 0. 030 | ||||